Exploring the association between macroeconomic indicators and dialysis mortality

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 10, 2012, Pages 1655-1663

  Kramer, Anneke ^a   Stel, Vianda S ^a   Caskey, Fergus J ^a   Stengel, Benedicte ^a   Elliott, Robert F ^a   Covic, Adrian ^a   Geue, Claudia ^a   Cusumano, Ana ^a   MacLeod, Alison M ^a   Jager, Kitty J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL INDICATOR; DIALYSIS; DISEASE REGISTRY; FEMALE; HEALTH SERVICE; HUMAN; ICELAND; MALE; MORTALITY; OUTCOME ASSESSMENT; QUESTIONNAIRE; RISK FACTOR; ROMANIA; SURVIVAL RATE;

AGE FACTORS; AGED; FEMALE; GROSS DOMESTIC PRODUCT; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH SERVICES RESEARCH; HEALTH STATUS; HEALTHCARE DISPARITIES; HUMANS; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY OF HEALTH CARE; REGISTRIES; RENAL DIALYSIS; RESIDENCE CHARACTERISTICS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84867263386     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10461011     Document Type: Article

References (48)

1. Held PJ, Brunner F, Odaka M, García JR, Port FK, Gaylin DS: Fiveyear survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis 15: 451-457, 1990
2. Marcelli D, Stannard D, Conte F, Held PJ, Locatelli F, Port FK: ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int 50: 1013-1018, 1996
3. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 14: 3270-3277, 2003
4. vanManen JG, van Dijk PC, Stel VS, Dekker FW, Clèries M, Conte F, Feest T, Kramar R, Leivestad T, Briggs JD, Stengel B, Jager KJ: Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant 22: 187-195, 2007
5. Kuhlmann MK, Yoshino M, Levin NW: Differences in cardiovascular mortality rates among hemodialysis patients in the United States and Japan: The importance of background cardiovascular mortality. Hemodial Int 8: 394-399, 2004
6. van Dijk PC, Zwinderman AH, Dekker FW, Schön S, Stel VS, Finne P, Jager KJ: Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe. Kidney Int 71: 53-59, 2007
7. Yoshino M, Kuhlmann MK, Kotanko P, Greenwood RN, Pisoni RL, Port FK, Jager KJ, Homel P, Augustijn H, de Charro FT, Collart F, Erek E, Finne P, Garcia-Garcia G, Grönhagen-Riska C, Ioannidis GA, Ivis F, Leivestad T, Løkkegaard H, Lopot F, Jin DC, Kramar R, Nakao T, Nandakumar M, Ramirez S, van der Sande FM, Schön S, Simpson K, Walker RG, Zaluska W, Levin NW: International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol 17: 3510-3519, 2006
8. Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, Rayner HC, Saito A, Sands JJ, Saran R, Gillespie B, Wolfe RA, Port FK: Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: An instrumental variable analysis. Am J Kidney Dis 53: 475-491, 2009
9. De Vecchi AF, Dratwa M, Wiedemann ME: Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: Costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 14[Suppl 6]: 31-41, 1999
10. Foley RN, Hakim RM: Why is the mortality of dialysis patients in the United States much higher than the rest of the world? J Am Soc Nephrol 20: 1432-1435, 2009
11. Kjellstrand CM, Blagg CR: Differences in dialysis practice are the main reasons for the high mortality rate in the United States compared to Japan. Hemodial Int 7: 67-71, 2003
12. Lameire N: Management of the hemodialysis patient: A European perspective. Blood Purif 20: 93-102, 2002
13. Kerr PG: International differences in hemodialysis delivery and their influence on outcomes. Am J Kidney Dis 58: 461-470, 2011
14. Dor A, Pauly MV, Eichleay MA, Held PJ: End-stage renal disease and economic incentives: The International Study of Health Care Organization and Financing (ISHCOF). Int J Health Care Finance Econ 7: 73-111, 2007
15. Garg PP, Frick KD, Diener-West M, Powe NR: Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation. N Engl J Med 341: 1653-1660, 1999
16. Irvin RA: Quality of care differences by ownership in United States renal dialysis facilities. ASAIO J 46: 775-778, 2000
17. Foley RN, Fan Q, Liu J, Gilbertson DT, Weinhandl ED, Chen SC, Collins AJ: Comparative mortality of hemodialysis patients at forprofit and not-for-profit dialysis facilities in the United States, 1998 to 2003: A retrospective analysis. BMC Nephrol 9: 6, 2008
18. Caskey FJ, Kramer A, Elliott RF, Stel VS, Covic A, Cusumano A, Geue C, Macleod AM, Zwinderman AH, Stengel B, Jager KJ: Global variation in renal replacement therapy for end-stage renal disease. Nephrol Dial Transplant 26: 2604-2610, 2011
19. Caskey FJ, Stel VS, Elliott RF, Jager KJ, Covic A, Cusumano A, Geue C, Kramer A, Stengel B, MacLeod AM: The EVEREST study: An international collaboration. NDT Plus 3: 28-36, 2010
20. Arends LR, Hunink MG, Stijnen T: Meta-analysis of summary survival curve data. Stat Med 27: 4381-4396, 2008
21. Tripepi G, Jager KJ, Dekker FW, Zoccali C: Testing for causality and prognosis: Etiological and prognostic models. Kidney Int 74: 1512-1515, 2008
22. Tripepi G, Jager KJ, Dekker FW, Zoccali C: Linear and logistic regression analysis. Kidney Int 73: 806-810, 2008
23. Jager KJ, Zoccali C, Macleod A, Dekker FW: Confounding: What it is and how to deal with it. Kidney Int 73: 256-260, 2008
24. van Stralen KJ, Dekker FW, Zoccali C, Jager KJ: Confounding. Nephron Clin Pract 116: c143-c147, 2010
25. Friedman EA: International comparisons of survival on dialysis: Are they reliable? Hemodial Int 7: 59-66, 2003
26. Yang WC, Hwang SJ; Taiwan Society of Nephrology: Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: The impact of national health insurance. Nephrol Dial Transplant 23: 3977-3982, 2008
27. Lambie M, Rayner HC, Bragg-Gresham JL, Pisoni RL, Andreucci VE, Canaud B, Port FK, Young EW: Starting and withdrawing haemodialysis-associations between nephrologists' opinions, patient characteristics and practice patterns (data from the Dialysis Outcomes and Practice Patterns Study). Nephrol Dial Transplant 21: 2814-2820, 2006
28. McKenzie JK, Moss AH, Feest TG, Stocking CB, Siegler M: Dialysis decision making in Canada, the United Kingdom, and the United States. Am J Kidney Dis 31: 12-18, 1998
29. Hwang SJ, Tsai JC, Chen HC: Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton) 15[Suppl 2]: 3-9, 2010
30. Registry ERA-EDTA: ERA-EDTA Registry Annual Report 2003-2005, Amsterdam, The Netherlands, Academic Medical Center, Department of Medical Informatics, 2007
31. US Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009
32. Xu Y, Dong J, Zuo L: Is frequency of patient-physician clinic contact important in peritoneal dialysis patients? Perit Dial Int 29 [Suppl 2]: S83-S89, 2009
33. Plantinga LC, Fink NE, Sadler JH, Levey AS, Levin NW, Rubin HR, Coresh J, Klag MJ, Powe NR: Frequency of patient-physician contact and patient outcomes in hemodialysis care. J Am Soc Nephrol 15: 210-218, 2004
34. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: Associationswith reduced mortality in the DOPPS. Kidney Int 69: 1222-1228, 2006
35. Hasegawa T, Bragg-Gresham JL, Yamazaki S, Fukuhara S, Akizawa T, Kleophas W, Greenwood R, Pisoni RL: Greater firstyear survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits. Clin J Am Soc Nephrol 4: 595-602, 2009
36. Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M: Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J KidneyDis 44[Suppl 2]: 34-38, 2004
37. OECD: Health at a Glance 2011: OECD Indicators, 2011. Available at: http://www.oecd.org/dataoecd/6/28/4910585. Accessed March 6, 2009
38. Wennberg JE, Fisher ES, Skinner JS: Geography and the debate over Medicare reform [published online ahead of print February 13, 2002]. Health Aff (Millwood) doi:10.1377/hlthaff.w2.96
39. Van Biesen W, Lameire N, Peeters P, Vanholder R: Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease. Int J Health Care Finance Econ 7: 133-148, 2007
40. Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group: Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360: 1395-1407, 2009
41. Solomon SD, Uno H, Lewis EF, Eckardt KU, Lin J, Burdmann EA, de Zeeuw D, Ivanovich P, Levey AS, Parfrey P, Remuzzi G, Singh AK, Toto R, Huang F, Rossert J, McMurray JJ, Pfeffer MA; Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) Investigators: Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med 363: 1146-1155, 2010
42. Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garrett L, Ling BN, Chasan-Taber S, Dillon MA, Blair AT, Burke SK: Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int 72: 1130-1137, 2007
43. Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, Ritz E; German Diabetes and Dialysis Study Investigators: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353: 238-248, 2005
44. Goodkin DA, Young EW, Kurokawa K, Prütz KG, Levin NW: Mortality among hemodialysis patients in Europe, Japan, and the United States: Case-mix effects. Am J Kidney Dis 44[Suppl 2]: 16-21, 2004
45. Robinson BM, Port FK: International hemodialysis patient outcomes comparisons revisited: The role of practice patterns and other factors. Clin J Am Soc Nephrol 4[Suppl 1]: S12-S17, 2009
46. United Nations Development Programme: Human Development Index Report 2006-Beyond Scarcity: Power, Poverty and the Global Water Crisis, New York, United Nations, 2006
47. World Health Organization: The World Health Report 2000-Health Systems: Improving Performance, Geneva, Switzerland, World Health Organization, 2010
48. Marinovich S, Lavorato C, Celia E, Moriñigo C, Bisignano L, Soratti M, Hansen Krogh D: Registro Argentino de Diálisis Crónica. Sociedad Argentina de Nefrología (SAN) and Instituto Nacional Central Unico Coordinador de Ablación e Implante (INCUCAI), Buenos Aires, Argentina, 2008